105 startups in Boston filed a Form D in the last 12 months. Together they reported $3.08B sold in 97 new rounds. The median round was $5.5M.
Startups
105
filed in 12 months
Reported new funding
$3.08B
97 rounds
Median round
$5.5M
new rounds
Largest rounds
Latest filings
| Company | Industry | Filed | Amount sold | Investors |
|---|---|---|---|---|
| Energy & Climate | Nov 12, 2026 | $3.5M ↗ | 7 | |
| Healthcare | Nov 12, 2026 | $100K ↗ | 2 | |
| Enterprise Software | Nov 10, 2026 | $15.3M ↗ | 10 | |
| Biotech & Pharma | Nov 4, 2026 | $5.4M ↗ | 7 | |
| Biotech & Pharma | Nov 4, 2026 | $2.0M ↗ | 13 | |
| Media, Entertainment & Gaming | Oct 30, 2026 | $150K ↗ | 1 | |
| Enterprise Software | Oct 22, 2026 | $4.9M ↗ | 3 | |
| Artificial Intelligence | Oct 22, 2026 | $97.3M ↗ | 18 | |
| Industrial & Robotics | Oct 21, 2026 | $2.4M ↗ | 3 | |
| FinTech & Financial Services | Oct 21, 2026 | $2.0M ↗ | 1 | |
| Biotech & Pharma | Oct 20, 2026 | $5.5M ↗ | 8 | |
| Healthcare | Oct 19, 2026 | $1.3M ↗ | 4 | |
| Healthcare | Oct 13, 2026 | $850K ↗ | 3 | |
| Artificial Intelligence | Oct 6, 2026 | $100K ↗ | 1 | |
| Biotech & Pharma | Sep 28, 2026 | $9.9M ↗ | 3 |
Boston companies 310
| Company | Industry | City | Latest filing | Latest raise |
|---|---|---|---|---|
| Not classified yet | Boston | Mar 3, 2023 | $1.8M | |
| Biotech & Pharma | Boston | Feb 14, 2023 | $12.2M | |
| Not classified yet | Boston | Feb 9, 2023 | $1.0M | |
| Not classified yet | Boston | Jan 23, 2023 | $5.0M | |
| Not classified yet | Boston | Jan 20, 2023 | $9.0M | |
| Not classified yet | Boston | Jan 19, 2023 | — | |
| Not classified yet | Boston | Jan 18, 2023 | $150K | |
| Biotech & Pharma | Boston | Jan 6, 2023 | $1.1M | |
| Not classified yet | Boston | Jan 5, 2023 | $50K | |
| Not classified yet | Boston | Aug 4, 2015 | $12.0M |
How this page is built
Startups are the private companies counted as startups (see our startup funding data), placed by the address on their latest Form D. Registered-agent and virtual-office addresses are not counted as a location. Public companies, foreign issuers and business-combination filings are excluded.